Literature DB >> 10884952

Should we use a case-crossover design?

M Maclure1, M A Mittleman.   

Abstract

The first decade of experience with case-crossover studies has shown that the design applies best if the exposure is intermittent, the effect on risk is immediate and transient, and the outcome is abrupt. However, this design has been used to study single changes in exposure level, gradual effects on risk, and outcomes with insidious onsets. To estimate relative risk, the exposure frequency during a window just before outcome onset is compared with exposure frequencies during control times rather than in control persons. One or more control times are supplied by each of the cases themselves, to control for confounding by constant characteristics and self-confounding between the trigger's acute and chronic effects. This review of published case-crossover studies is designed to help the reader prepare a better research proposal by understanding triggers and deterrents, target person times, alternative study bases, crossover cohorts, induction times, effect and hazard periods, exposure windows, the exposure opportunity fallacy, a general likelihood formula, and control crossover analysis.

Entities:  

Mesh:

Year:  2000        PMID: 10884952     DOI: 10.1146/annurev.publhealth.21.1.193

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  202 in total

Review 1.  Investigating neighborhood and area effects on health.

Authors:  A V Diez Roux
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

2.  Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients.

Authors:  Ingrid S Lundgren; Chuan Zhou; Frances R Malone; Nancy G McAfee; Soren Gantt; Danielle M Zerr
Journal:  Pediatr Infect Dis J       Date:  2012-04       Impact factor: 2.129

3.  Reduction in purchases of sugar-sweetened beverages among low-income Black adolescents after exposure to caloric information.

Authors:  Sara N Bleich; Bradley J Herring; Desmond D Flagg; Tiffany L Gary-Webb
Journal:  Am J Public Health       Date:  2011-12-15       Impact factor: 9.308

4.  Desert dust exposure is associated with increased risk of asthma hospitalization in children.

Authors:  Kumiko T Kanatani; Isao Ito; Wael K Al-Delaimy; Yuichi Adachi; William C Mathews; Joe W Ramsdell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

5.  The case-crossover study: a novel design in evaluating transient fatigue as a risk factor for road traffic accidents.

Authors:  David A Lombardi
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

6.  A case-crossover study of sleep and work hours and the risk of road traffic accidents.

Authors:  Francesca Valent; Stefano Di Bartolomeo; Riccardo Marchetti; Rodolfo Sbrojavacca; Fabio Barbone
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

7.  Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type.

Authors:  Kenneth R Conner; Rebecca J Houston; Marc T Swogger; Yeates Conwell; Sungeun You; Hua He; Stephanie A Gamble; Arthur Watts; Paul R Duberstein
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

8.  Purine-rich foods intake and recurrent gout attacks.

Authors:  Yuqing Zhang; Clara Chen; Hyon Choi; Christine Chaisson; David Hunter; Jingbo Niu; Tuhina Neogi
Journal:  Ann Rheum Dis       Date:  2012-05-30       Impact factor: 19.103

Review 9.  Effects of stress on the development and progression of cardiovascular disease.

Authors:  Mika Kivimäki; Andrew Steptoe
Journal:  Nat Rev Cardiol       Date:  2017-12-07       Impact factor: 32.419

10.  Risk of a thrombotic event after the 6-week postpartum period.

Authors:  Hooman Kamel; Babak B Navi; Nandita Sriram; Dominic A Hovsepian; Richard B Devereux; Mitchell S V Elkind
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.